213 related articles for article (PubMed ID: 29724919)
21. [Outcome and treatment among patients with multidrug-resistant tuberculosis].
Ramírez Lapausa M; Pascual Pareja JF; Amer López M; Vidal Pérez JL; Noguerado Asensio A
Med Clin (Barc); 2012 May; 138(15):643-9. PubMed ID: 22440146
[TBL] [Abstract][Full Text] [Related]
22. Management of multidrug resistant tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
[TBL] [Abstract][Full Text] [Related]
23. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
Koenig R
Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
[No Abstract] [Full Text] [Related]
24. Management of drug-resistant TB with individualised DST--the way forward?
Singhal T; Gupta N
J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
[No Abstract] [Full Text] [Related]
25. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
26. Multi-drug resistant tuberculosis, ten years later.
Caminero Luna JA; Pérez Mendoza G; Rodríguez de Castro F
Med Clin (Barc); 2021 Apr; 156(8):393-401. PubMed ID: 33531151
[TBL] [Abstract][Full Text] [Related]
27. [New tuberculosis drugs in resistant and multiresistant tuberculosis].
Ramírez Lapausa M; Pascual Pareja JF; Noguerado Asensio A
Med Clin (Barc); 2013 Oct; 141(7):306-13. PubMed ID: 23540388
[TBL] [Abstract][Full Text] [Related]
28. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
[No Abstract] [Full Text] [Related]
29. Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
Millán-Lou MI; Ollé-Goig JE; Tortola MT; Martin C; Samper S
Int J Tuberc Lung Dis; 2016 Feb; 20(2):150-3. PubMed ID: 26792464
[TBL] [Abstract][Full Text] [Related]
30. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
31. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
[TBL] [Abstract][Full Text] [Related]
32. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
[TBL] [Abstract][Full Text] [Related]
34. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
Baylan O
Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
[TBL] [Abstract][Full Text] [Related]
35. MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India.
James P; Gupta R; Christopher DJ; Thankagunam B; Veeraraghavan B
Clin Respir J; 2011 Jan; 5(1):19-25. PubMed ID: 21159137
[TBL] [Abstract][Full Text] [Related]
36. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
37. Recruitment challenges for clinical trials with novel regimens for drug-resistant tuberculosis.
Siwendu S; Mitchell M; Diacon AH; von Groote-Bidlingmaier F
Eur Respir J; 2016 Feb; 47(2):670-2. PubMed ID: 26647435
[No Abstract] [Full Text] [Related]
38. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
[TBL] [Abstract][Full Text] [Related]
39. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
Okulovskaia SS; Gurevich GL; Bogomazova AV
Probl Tuberk; 1999; (6):6-8. PubMed ID: 10715945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
